Geode Capital Management
IMMX icon

Geode Capital Management’s Immix Biopharma IMMX Stock Holding History

Geode Capital Management’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.22M Buy
463,384
+217,328
+88% +$1.6M ﹤0.01% 2824
2025
Q4 		$1.29M Buy
246,056
+58,580
+31% +$241K ﹤0.01% 3302
2025
Q3 		$392K Buy
187,476
+26,361
+16% +$63.3K ﹤0.01% 3709
2025
Q2 		$334K Buy
161,115
+373
+0.2% +$751 ﹤0.01% 3690
2025
Q1 		$270K Buy
160,742
+10,660
+7% +$20.1K ﹤0.01% 3750
2024
Q4 		$330K Hold
150,082
– – ﹤0.01% 3734
2024
Q3 		$224K Buy
150,082
+7,954
+6% +$16K ﹤0.01% 3867
2024
Q2 		$281K Buy
142,128
+17,358
+14% +$39.9K ﹤0.01% 3788
2024
Q1 		$383K Buy
124,770
+41,343
+50% +$160K ﹤0.01% 3702
2023
Q4 		$577K Buy
83,427
+10,405
+14% +$47.1K ﹤0.01% 3555
2023
Q3 		$250K Buy
73,022
+12,696
+21% +$29.8K ﹤0.01% 3890
2023
Q2 		$162K Sell
60,326
-19,396
-24% -$40.6K ﹤0.01% 4131
2023
Q1 		$145K Buy
79,722
+3,185
+4% +$7.04K ﹤0.01% 4189
2022
Q4 		$175K Sell
76,537
-232
-0.3% -$309 ﹤0.01% 4167
2022
Q3 		$104K Buy
76,769
+3,436
+5% +$7.51K ﹤0.01% 4556
2022
Q2 		$190K Buy
+73,333
New +$143K ﹤0.01% 4298

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Geode Capital Management's IMMX Position: Q1 2026 in Review

Geode Capital Management increased its Immix Biopharma (IMMX) stake by 88% in Q1 2026, buying an estimated $1.6M and bringing the position to 463,384 shares worth $4.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

Geode Capital Management first reported a position in IMMX in Q2 2022 and has held it in 16 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Geode Capital Management held 463,384 shares of Immix Biopharma worth $4.22M as of Q1 2026.
  • Geode Capital Management bought 217,328 Immix Biopharma shares in Q1 2026, an estimated $1.6M.
  • Immix Biopharma made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2824 holding.
  • Geode Capital Management first reported a position in Immix Biopharma in Q2 2022 and has held it in 16 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.